< Back to previous page
Researcher
Ghislain Opdenakker
- Disciplines:Immunology
Affiliations
- Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 2001 → Today - Molecular Immunology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 25
- Regulation and function of immune cell proteases in multiple sclerosis.From1 Jan 2021 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Study and selective targeting of monomeric and trimeric gelatinase B/ MMP-9From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Functional analysis of active alpha-2-macroglobulin/protease complexes and their potential applications in protease-driven diseasesFrom1 Oct 2019 → 30 Sep 2022Funding: FWO fellowships
- Immunomodulation of wound healingFrom1 Jun 2019 → 4 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Functional subset definition and molecular regulation of neutrophils and natural killer cells in infection and inflammation.From1 Oct 2017 → 30 Sep 2023Funding: BOF - projects, Fund Recuperation Fiscal Exemption
- Role of MMP-9 in systemic lupus erythematosus.From1 Oct 2016 → 30 Sep 2019Funding: FWO fellowships
- Post-translational modifications and multiple sclerosis: assessment of proteolysis and citrullination as disease-modifiers in animal models of neuroinflammation.From1 Jan 2016 → 31 Dec 2017Funding: Nonprofit institution or equivalents
- Novel posttranslational modifications of gelatinase B/matrix metalloproteinase-9From1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Wound healing in diabetes with innate immune molecules and cellsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
Publications
41 - 50 of 274
- Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)(2020)
Authors: Mirre De Bondt, Ghislain Opdenakker, Sofie Struyf
- De pathogene rol van hemozoïne en endotheelactivatie in malaria geassocieerde acute respiratory distress syndrome(2020)
Authors: Thao-Thy Pham, Philippe Van den Steen, Ghislain Opdenakker
- Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format(2020)
Authors: Lise Boon, Ghislain Opdenakker
- Remnant Epitopes Generating Autoimmunity: From Model to Useful Paradigm(2020)
Authors: Ghislain Opdenakker, Jo Van Damme
Pages: 367 - 378 - Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities(2020)
Authors: Nele Berghmans, Ghislain Opdenakker, Jo Van Damme, Sofie Struyf
Pages: 453 - 462 - Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination(2020)
Authors: Jennifer Vandooren, Chris Van den Haute, Veerle Baekelandt, Ghislain Opdenakker
Pages: 5028 - 5038 - Protease propeptide structures, mechanisms of activation, and functions(2020)
Authors: Lise Boon, Jennifer Vandooren, Ghislain Opdenakker
Pages: 111 - 165 - Functionele regulatie van MMP-9 door posttranslationele modificaties(2020)
Authors: Lise Boon, Ghislain Opdenakker
- The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor(2020)
Authors: Marc Ferrante, Gert Van Assche, Ghislain Opdenakker, Séverine Vermeire
Pages: 176 - 184 - Galectin-1 studies in proliferative diabetic retinopathy(2020)
Authors: Ghislain Opdenakker
Pages: E1 - E12